oral semaglutide trade name US FDA accepts Novo Nordisk's application for Wegovy for weight loss Novo Nordisk medicines containing semaglutide

The threat of substitutes in the Semaglutide market is moderate

They are also known as GLP-1 analogues or incretin mimetics

One study showed that low doses can be beneficial for 3-6 month treatments, at which point, 80% of responsive participants experienced normal menstrual cycles

Significant appetite suppression can lead to inadequate protein intake, micronutrient deficiencies, and muscle mass loss if dietary composition is not actively managed

N Engl J Med 358(6):580591 Garvey WT, Van Gaal L, Leiter LA, Vijapurkar U, List J, Cuddihy R et al (2018) Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes

If you are struggling with cost, side effects, or adherence, contact your provider or explore medication options explicitly designed to be affordable and flexible